12.10.25 -- What The FDA Says About Investigator Responsibilities In DCTs

Learn how to work effectively with clinical suppliers for accurate forecasting and comparator sourcing. Find best practices for leveraging the resources of sourcing vendors to anticipate supply delays.

Dive into the dynamic world of GLP-1 receptor agonists, where we explore the current landscape, the challenges ahead, and the complexities of early-phase drug development.

Gain a comprehensive overview of how sponsors can accelerate clinical trial start-up in Australia, leveraging the nation’s unique strengths as a global hub for clinical research.

Shipping and storing leading-edge therapeutics require complex logistics, but enhanced automation and process simplification ensure that sites and patients have the drugs they need when they need them.

Discover how integrating clinical execution with investor strategy can strengthen your position in a tougher capital landscape and accelerate your path to market.

Accelerate your therapy's path to market and create better experiences with the right partner to provide end-to-end Clinical Development expertise.

Selecting the right functional service provider (FSP) is a critical factor in advancing clinical research programs efficiently, and this reimagined FSP model prioritizes each client’s unique objectives.

How can you turn capacity limits into enrollment momentum and ensure timelines stay on track while also expanding access to diverse patient populations?

We believe that delivering meaningful results begins with meeting patients where they are — whether in their homes, within their communities, or in familiar gathering places.